InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (INM) — Form SCHEDULE 13D: Ownership over 5% (active)
About this filing
InMed Pharmaceuticals Inc. (INM) filed Form SCHEDULE 13D (ownership over 5% (active)) with the SEC on Nov 12, 2026. A Schedule 13D reports an investor owning more than 5% of the company who may seek to influence it.
Key facts
- Document
- —
More INM filings
- SC 13G
Filed Nov 13, 2026
- SC 13G
Filed Nov 13, 2026
- 4
Filed Nov 12, 2026
- 4
Filed Nov 12, 2026
- 4
Filed Nov 12, 2026
- 4
Filed Nov 12, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.